These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1439913)

  • 1. The costs of diabetes and its complications.
    Leese B
    Soc Sci Med; 1992 Nov; 35(10):1303-10. PubMed ID: 1439913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Costs of temporary disability in Spain related to diabetes mellitus and its complications].
    Vicente-Herrero MT; Terradillos García MJ; Capdevila García LM; Ramírez Iñiguez de la Torre MV; López-González AA
    Endocrinol Nutr; 2013 Oct; 60(8):447-55. PubMed ID: 23726468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach.
    Marcellusi A; Viti R; Mecozzi A; Mennini FS
    Eur J Health Econ; 2016 Mar; 17(2):139-47. PubMed ID: 25427540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
    Köster I; Hauner H; von Ferber L
    Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of excess costs of care and production losses because of morbidity in diabetic patients.
    Olsson J; Persson U; Tollin C; Nilsson S; Melander A
    Diabetes Care; 1994 Nov; 17(11):1257-63. PubMed ID: 7821164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
    Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
    Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of diabetes in Norway 2011.
    Sørensen M; Arneberg F; Line TM; Berg TJ
    Diabetes Res Clin Pract; 2016 Dec; 122():124-132. PubMed ID: 27837695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of diabetes in Latin America and the Caribbean.
    Barceló A; Aedo C; Rajpathak S; Robles S
    Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic costs of diabetes mellitus: critical review and cost-benefit evaluation of proposed strategies for its reduction].
    Rubio JA; Alvarez J
    Aten Primaria; 1998 Sep; 22(4):239-55. PubMed ID: 9803577
    [No Abstract]   [Full Text] [Related]  

  • 14. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications.
    Zhuo X; Zhang P; Hoerger TJ
    Am J Prev Med; 2013 Sep; 45(3):253-61. PubMed ID: 23953350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
    Hex N; Bartlett C; Wright D; Taylor M; Varley D
    Diabet Med; 2012 Jul; 29(7):855-62. PubMed ID: 22537247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of diabetic patients in India: A review.
    Bansode B; Jungari DS
    Diabetes Metab Syndr; 2019; 13(4):2469-2472. PubMed ID: 31405662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group.
    Rodby RA; Firth LM; Lewis EJ
    Diabetes Care; 1996 Oct; 19(10):1051-61. PubMed ID: 8886549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost burden of diabetes mellitus: the evidence from Germany--the CoDiM study.
    Köster I; von Ferber L; Ihle P; Schubert I; Hauner H
    Diabetologia; 2006 Jul; 49(7):1498-504. PubMed ID: 16752168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.